- JP-listed companies
- CHUGAI PHARMACEUTICAL CO., LTD.
CHUGAI PHARMACEUTICAL CO., LTD.JP:4519
Market cap
¥11.43T
P/E ratio
35.1x
Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | |
Revenue | - | - | 579,787 | 686,184 | 786,946 | 999,759 | 1,259,946 | 1,111,367 |
Sales | - | - | 527,844 | 588,896 | 633,314 | 802,836 | 1,039,247 | 974,493 |
Other revenues | - | - | - | - | - | - | 220,479 | 136,874 |
Cost of sales | - | - | 262,847 | 266,071 | 273,465 | 338,147 | 476,251 | 413,306 |
Gross profit | - | - | 316,940 | 420,113 | 513,481 | 661,612 | 783,695 | 698,061 |
Research and development expenses | - | - | 99,202 | 107,942 | 117,850 | 137,299 | 149,626 | 174,868 |
Selling, general and administrative expenses | - | - | - | - | - | - | 100,477 | 112,580 |
Other operating income (expense) | - | - | - | - | - | - | -64 | 28,561 |
Operating profit (loss) | - | - | 124,323 | 210,597 | 301,230 | 421,897 | 533,309 | 439,174 |
Finance costs | - | - | 111 | 125 | 62 | 48 | 61 | 27 |
Other financial income (expense) | - | - | 449 | 545 | -1,477 | 76 | 52 | 4,674 |
Other expenses | - | - | 3,212 | 3,124 | 1,504 | 2,540 | 2,134 | - |
Profit (loss) before tax | - | - | 121,449 | 207,893 | 298,188 | 419,385 | 531,166 | 443,821 |
Income tax expense | - | - | 28,370 | 50,333 | 83,455 | 116,390 | 156,737 | 118,349 |
Profit (loss) | - | - | 93,079 | 157,560 | 214,733 | 302,995 | 374,429 | 325,472 |
Owners of parent | - | - | 92,488 | 157,560 | 214,733 | 302,995 | 374,429 | 325,472 |
Basic earnings (loss) per share | - | - | 169.08 | 287.84 | 130.66 | 184.29 | 227.64 | 197.83 |
Diluted earnings (loss) per share | - | - | 168.8 | 287.43 | 130.53 | 184.17 | 227.57 | 197.8 |